Clinical Trial Update: A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase I clinical trial update for decitabine, lisaftoclax, and olverembatinib in advanced chronic myeloid leukemia and Philadelphia chromosome-positive acute my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Acute Myeloid Leukemia

Drugs mentioned

• Dacogen (decitabine)
• Lisaftoclax (APG-2575)
• Olverembatinib (Olverembatinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Chronic Myeloid Leukemia, Philadelphia Chromosome-Positive Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING